One-year safety and effectiveness of insulin degludec in patients with diabetes mellitus in routine clinical practice in India—TRUST (Tresiba real-world use study)

Objective: This post-authorization safety study (PASS) was conducted to evaluate the long-term safety and effectiveness of insulin degludec in patients with diabetes mellitus (DM) requiring insulin therapy in routine clinical practice in India. Methods: Data on glycated hemoglobin (HbA1c) and advers...

Volledige beschrijving

Bibliografische gegevens

Hoofdauteurs:	Jothydev Kesavadev, L.Sreenivasa Murthy, Tirthankar Chaudhury, Sadasiva Rao Yalamanchi, J. Giri, Sunil Gupta, Sanjeev Phatak, K.D. Modi, Sanjay Chatterjee, Aparna Manjunath, Manjunatha Revanna, Arpandev Bhattacharya
Formaat:	Artigo
Taal:	Inglês
Gepubliceerd in:	Elsevier 2022-06-01
Reeks:	Metabolism Open
Onderwerpen:	Insulin degludec Diabetes mellitus Safety Post-authorization safety study Effectiveness Real-world evidence
Online toegang:	http://www.sciencedirect.com/science/article/pii/S2589936822000226
Tags:	Voeg label toe Geen labels, Wees de eerste die dit record labelt!